These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 9819031

  • 1. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
    Sørensen BB, Rao LV.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M, Golino P, Cirillo P, Pascucci I, Scognamiglio A, Ravera A, Esposito N, Battaglia C, Guarino A, Chiariello M.
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
    Petersen LC, Nørby PL, Branner S, Sørensen BB, Elm T, Stennicke HR, Persson E, Bjørn SE.
    Thromb Res; 2005 Jan; 116(1):75-85. PubMed ID: 15850611
    [Abstract] [Full Text] [Related]

  • 6. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
    Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Hedner U, Roberts HR.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025
    [Abstract] [Full Text] [Related]

  • 7. Tissue factor on cells.
    Rao LV, Pendurthi UR.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S27-35. PubMed ID: 9819026
    [Abstract] [Full Text] [Related]

  • 8. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action.
    Rao LV, Ezban M.
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S135-43. PubMed ID: 10850580
    [Abstract] [Full Text] [Related]

  • 9. Ca2+ in the first epidermal growth factor-like domain of activated factor VII.
    Persson E, Nielsen LS.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S79-81. PubMed ID: 9819033
    [Abstract] [Full Text] [Related]

  • 10. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
    Reuning U, Preissner KT, Müller-Berghaus G.
    Thromb Haemost; 1993 Feb 01; 69(2):197-204. PubMed ID: 8456434
    [Abstract] [Full Text] [Related]

  • 11. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis.
    Versteeg HH, Spek CA, Richel DJ, Peppelenbosch MP.
    Oncogene; 2004 Jan 15; 23(2):410-7. PubMed ID: 14724569
    [Abstract] [Full Text] [Related]

  • 12. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV, Petrovan RJ, Ruf W, Olson AJ.
    Proteins; 2003 Nov 15; 53(3):640-8. PubMed ID: 14579355
    [Abstract] [Full Text] [Related]

  • 13. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
    Arnold CS, Parker C, Upshaw R, Prydz H, Chand P, Kotian P, Bantia S, Babu YS.
    Thromb Res; 2006 Nov 15; 117(3):343-9. PubMed ID: 16378835
    [Abstract] [Full Text] [Related]

  • 14. Enhancing the anticoagulant potency of soluble tissue factor mutants by increasing their affinity to factor VIIa.
    Yang J, Lee GF, Riederer MA, Kelley RF.
    Thromb Haemost; 2002 Mar 15; 87(3):450-8. PubMed ID: 11916078
    [Abstract] [Full Text] [Related]

  • 15. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor.
    Muth H, Kreis I, Zimmermann R, Tillmanns H, Hölschermann H.
    Thromb Haemost; 2005 Nov 15; 94(5):1028-34. PubMed ID: 16363246
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
    Golino P, Ragni M, Cirillo P, D'Andrea D, Scognamiglio A, Ravera A, Buono C, Ezban M, Corcione N, Vigorito F, Condorelli M, Chiariello M.
    Circ Res; 2005 Nov 15; 82(1):39-46. PubMed ID: 9440703
    [Abstract] [Full Text] [Related]

  • 17. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Kamikubo Y, Sumiyoshi A.
    Thromb Haemost; 1997 Sep 15; 78(3):1138-41. PubMed ID: 9308767
    [Abstract] [Full Text] [Related]

  • 18. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF, Yang J, Eigenbrot C, Moran P, Peek M, Lipari MT, Kirchhofer D.
    Biochemistry; 2004 Feb 10; 43(5):1223-9. PubMed ID: 14756558
    [Abstract] [Full Text] [Related]

  • 19. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E, Olsen OH.
    FEBS J; 2009 Jun 10; 276(11):3099-109. PubMed ID: 19490111
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancer.
    Zerbib P, Grimonprez A, Corseaux D, Mouquet F, Nunes B, Petersen LC, Susen S, Ung A, Hebbar M, Pruvot FR, Chambon JP, Jude B.
    J Surg Res; 2009 May 15; 153(2):239-45. PubMed ID: 19062044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.